Aerie Pharma (AERI) Reports Q2 Loss of $1.40/Share

Aerie Pharma (NASDAQ: AERI) reported Q2 EPS of ($1.40), versus ($0.82) reported last year. Revenue for the quarter came in at $2.42 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Palo Alto Networks (PANW) PT Raised to $415 at Rosenblatt
• RYET wins RMB5.99M YeeZo platform contract for 10 labs